Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
Weber Announces Management Transition and Provides Business Update
Alan Matula Appointed Interim CEO
Company Provides Preliminary Estimates for Fiscal Third Quarter 2022 Results; Will Report Final
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
Meta Platforms (META)
GameStop (GME)
Invesco QQQ Trust (QQQ)
Weber (WEBR)
Apple (AAPL)
AMC Entertainment
Today's 5 Stock Ideas:
Zscaler (ZS) - A play on cybersecurity. The company will report Q3 results after market close Thursday.
BlackSky (BKSY) - In one of Wednesday's hottest news items, the US